Abstract

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis

Author(s): Lyon Joanna

Issue: Nov/Dec 2012 - Volume 16, Number 6

Page(s): 456-460

Download in electronic PDF format for $75
  • Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 1
  • Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 2
  • Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 3
  • Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 4
  • Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 5

Abstract

This article provides a discussion on the current problem of drug shortages within the U.S. and how compounded preparations serve as the only safe option as a source of medications during the crisis. Included are literature reviews concerning the reasons behind the increase in drug shortages and an update on the problem.

Related Keywords

  • drug shortages
  • drug safety
  • gray market drugs
  • U.S. Food and Drug Administration
  • DEA
  • drug contamination
  • active pharmaceutical ingredients

Related Categories

  • LEGAL
  • LITERATURE REVIEW
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2012
Pg. 456-460
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Author(s): Lyon Joanna
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 294-298
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Author(s): Allen Loyd V Jr, Williams LaVonn A
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 298-301
The Role of Compounding Pharmacists During Drug Shortages
Author(s): Ofei Kelvin
Mar/Apr 2011
Pg. 92
PreScription: Discontinued Drugs and Drug Shortages
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Mar/Apr 2022
Pg. 100-109
Allowing Compounding Pharmacies to Address Drug Shortages
Author(s): Broughel James
Jul/Aug 2012
Pg. 350-351
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Author(s): Allen Loyd V Jr, Williams LaVonn A
Nov/Dec 2011
Pg. 526-527
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Author(s): Williams LaVonn A
Nov/Dec 2006
Pg. 446-448
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 268
PreScription: Drug Shortages and Discontinued Drugs
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 35-36
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Author(s): Miller David G
Sep/Oct 2015
Pg. 389-390
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Author(s): Allen Loyd V Jr
Nov/Dec 2016
Pg. 457-458
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
Author(s):
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Jan/Feb 2019
Pg. 32-33
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Author(s): Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jul/Aug 2020
Pg. 296-297
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Author(s): Brunner Scott